Cancer Hospital Reports Findings in Cancer (Health insurance and inequalities in catastrophic health spending in cancer patients. A cross-sectional study in China): Cancer

Insurance Daily News

2024 MAY 30 (NewsRx) -- By a News Reporter-Staff News Editor at Insurance Daily News -- New research on Cancer is the subject of a report. According to news reporting originating in Beijing, People’s Republic of China, by NewsRx journalists, research stated, “To determine the role of social health insurance programs in reducing inequality in the incidence and intensity of catastrophic health expenditure (CHE) of cancer patients in China. A convenient sample of 2534 cancer patients treated in nine hospitals in 2015 and 2016 were followed up through face-to-face interviews in March-December 2018.”

The news reporters obtained a quote from the research from Cancer Hospital, “The incidence and intensity (mean positive overshoot) of CHE ( 40% household consumption) were calculated. About 72% of cancer patients experienced CHE events after insurance compensation, with the catastrophic mean positive overshoot amounting to 28.27% (SD: 15.83%) of the household consumption. Overall, social insurance contributed to a small percentage of drop in CHE events. Income-related inequality in CHE persisted before and after insurance compensation. Richer patients benefit more than poorer ones. Cancer treatment is associated with high incidence of CHE events in China.”

According to the news reporters, the research concluded: “The alleviating effect of social health insurance on CHE events is limited.”

For more information on this research see: Health insurance and inequalities in catastrophic health spending in cancer patients. A cross-sectional study in China. Gaceta Sanitaria, 2024;38:102397. Gaceta Sanitaria can be contacted at: Elsevier, 685 Route 202-206, Bridgewater, NJ 08807, USA. (Elsevier - www.elsevier.com; Gaceta Sanitaria - http://www.journals.elsevier.com/gaceta-sanitaria/)

Our news correspondents report that additional information may be obtained by contacting Jufang Shi, Office of Cancer Screening, National Cancer Center, National Clinical Research Center for Cancer, Cancer Hospital, Chinese Academy of Medical Sciences, Beijing, People’s Republic of China. Additional authors for this research include Wenqi Fu, Chaojie Liu, Wanqing Chen, Guoxiang Liu and Jie He.

The direct object identifier (DOI) for that additional information is: https://doi.org/10.1016/j.gaceta.2024.102397. This DOI is a link to an online electronic document that is either free or for purchase, and can be your direct source for a journal article and its citation.